Genetic Analysis AS (XSAT:GEAN)
Sweden · Delayed Price · Currency is SEK · Price in NOK 0.8050
-0.0350 (-4.17%)
At close: Aug 15, 2025
Genetic Analysis AS Market Cap
Genetic Analysis AS has a market cap or net worth of 52.17 million as of August 15, 2025. Its market cap has increased by 31.64% in one year.
Market Cap
52.17M
Enterprise Value
49.51M
Revenue
19.01M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.81
Market Cap Chart
Since October 1, 2021, Genetic Analysis AS's market cap has decreased from 235.48M to 52.17M, a decrease of -77.85%. That is a compound annual growth rate of -32.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 52.17M | 113.29% |
| Dec 30, 2024 | 24.46M | -31.37% |
| Dec 29, 2023 | 35.64M | -34.69% |
| Dec 30, 2022 | 54.57M | -66.71% |
| Dec 30, 2021 | 163.91M | -30.39% |
| Oct 1, 2021 | 235.48M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Investor AB | 898.62B |
| Atlas Copco AB | 701.01B |
| AB Volvo | 594.02B |
| EQT AB | 401.29B |
| ASSA ABLOY AB | 369.22B |
| Skandinaviska Enskilda Banken AB | 355.64B |
| Swedbank AB | 309.16B |
| Sandvik AB | 298.67B |